Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-057721
Filing Date
2012-08-14
Accepted
2012-08-14 13:36:25
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a12-16026_110q.htm 10-Q 891560
2 EX-31.1 a12-16026_1ex31d1.htm EX-31.1 10166
3 EX-31.2 a12-16026_1ex31d2.htm EX-31.2 9671
4 EX-32.1 a12-16026_1ex32d1.htm EX-32.1 7040
5 EX-32.2 a12-16026_1ex32d2.htm EX-32.2 5884
  Complete submission text file 0001104659-12-057721.txt   4951348

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ovas-20120630.xml EX-101.INS 519814
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ovas-20120630.xsd EX-101.SCH 50106
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ovas-20120630_cal.xml EX-101.CAL 46252
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ovas-20120630_def.xml EX-101.DEF 226082
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ovas-20120630_lab.xml EX-101.LAB 702719
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ovas-20120630_pre.xml EX-101.PRE 338213
Mailing Address 215 FIRST STREET SUITE 240 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 240 CAMBRIDGE MA 02142 617-902-0682
OvaScience, Inc. (Filer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54647 | Film No.: 121031420
SIC: 2835 In Vitro & In Vivo Diagnostic Substances